Last reviewed · How we verify
blood additional samples — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
blood additional samples (blood additional samples) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| blood additional samples TARGET | blood additional samples | Assistance Publique - Hôpitaux de Paris | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- blood additional samples CI watch — RSS
- blood additional samples CI watch — Atom
- blood additional samples CI watch — JSON
- blood additional samples alone — RSS
Cite this brief
Drug Landscape (2026). blood additional samples — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-additional-samples. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab